HCA earnings: next report 2026-07-24, real EPS beat/miss history, analyst consensus Buy, P/E 12.71. Updated 2026-07-23.
HCA Healthcare (HCA) Research Hub
HCA Healthcare (HCA) trades on NYSE, US in the Healthcare (Medical - Care Facilities) sector. As of 2026-09-11, shares last closed at 426.94 USD (+1.21%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 12.71, market cap 82.70B. This hub links to the full technical, earnings and options research available for HCA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Care Facilities) |
|---|---|
| Exchange | NYSE, US |
| Last close | 426.94 USD (+1.21%) |
| 52-week range | 363 USD – 433.5 USD |
| Trend regime | Range |
| 14-day RSI | 58 (Bullish) |
| Trailing P/E | 12.71 |
| Market cap | 82.70B |
| Dividend yield | 0.81% |
| Next earnings | 2026-07-24 |
Available research for HCA
Covered Call on HCA: how it works, illustrative setup around the real 426.94 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HCA: how it works, illustrative setup around the real 426.94 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HCA: how it works, illustrative setup around the real 426.94 USD price, max profit/loss, breakeven and when to use it. Educational.
HCA technical analysis: range, last 426.94 USD, RSI 58, 52w range 363 USD–433.5 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is HCA in?
HCA Healthcare (HCA) is classified under Healthcare (Medical - Care Facilities), listed on NYSE, US.
Is HCA in an uptrend or downtrend?
As of 2026-09-11, HCA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HCA's trailing P/E ratio?
HCA's trailing P/E is 12.71, with a market cap of 82.70B. See the earnings research page for full valuation detail.
When does HCA next report earnings?
HCA is next scheduled to report earnings on 2026-07-24, with a consensus EPS estimate of 7.56 USD.